Avignon, France

Michel Follet

This inventor holds 1 USPTO granted patent. Top assignee: Products Chimiques Auxiliaires Et De Synthese. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Follet. Retrieved from https://idiyas.com/inventor/michel-follet-8qo8b3y2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Michel Follet - Innovator in Pharmaceutical Synthesis**

Introduction

Michel Follet is a noteworthy inventor based in Avignon, France. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of important compounds. He is recognized for his innovative approach and dedication to advancing pharmaceutical chemistry.

Latest Patents

Michel has been awarded a patent for "Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation." This patent involves novel intermediates that facilitate the synthesis of (R)-tamsulosin, a medication often used to treat conditions related to the prostate. The preparation process outlined in his patent highlights his expertise in pharmaceutical synthesis.

Career Highlights

He works at Products Chimiques Auxiliaires et de Synthèse, where he continues to drive innovation in chemical synthesis. His career is marked by a commitment to developing new methodologies that improve the efficiency and effectiveness of pharmaceutical compounds.

Collaborations

Throughout his career, Michel has collaborated with esteemed colleagues like Valéry Dambrin and Jean-Yves Lenoir. Together, they have shared knowledge and insights, contributing to advancements in their field and fostering a collaborative work environment.

Conclusion

Michel Follet stands out as an inventor who has significantly impacted pharmaceutical synthesis. His innovative patent and collaborative efforts showcase his dedication to advancing medical science. As he continues to work at Products Chimiques Auxiliaires et de Synthèse, he remains a vital player in the development of pharmaceutical intermediates.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…